Pharmagen, Inc. specializes in the distribution of medical supplies and pharmaceuticals, primarily serving healthcare facilities across the United States. The company's competitive edge lies in its robust supply chain management and strategic partnerships with leading manufacturers, which enable it to maintain a gross margin of 63.3%. However, its current operational challenges are reflected in negative net and operating margins.
Business Overview
Pharmagen generates revenue through the wholesale distribution of pharmaceuticals and medical supplies to hospitals and clinics. Its pricing power is bolstered by long-term contracts with healthcare providers and exclusive agreements with certain manufacturers, allowing it to maintain a competitive advantage despite market pressures.
Changes in healthcare regulations impacting pharmaceutical distribution
Volume of medical supplies ordered by hospitals and clinics
Partnerships with new suppliers or manufacturers
Market share changes in the medical distribution sector
Risk Factors
Regulatory changes affecting pharmaceutical pricing and distribution
Technological advancements in supply chain management that could disrupt traditional distribution models
Emergence of new competitors with advanced logistics capabilities
Price competition from larger distribution networks
Negative operating margins leading to liquidity concerns
High reliance on short-term financing for inventory management
Macro Sensitivity
moderate - The healthcare sector is somewhat insulated from economic downturns, but demand for medical supplies can fluctuate with changes in consumer spending and healthcare budgets.
Interest rates affect Pharmagen primarily through financing costs for inventory and operational expenses. Higher rates could increase borrowing costs, impacting profitability.
minimal - The company operates with a negative debt/equity ratio, indicating a lack of reliance on external credit.
Profile
growth - Investors may be drawn to potential recovery and growth opportunities as the company stabilizes its operations.
high - The stock has shown extreme volatility, with a 900% return over the past year, indicating significant market speculation.
Explore More
Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
